138 related articles for article (PubMed ID: 19445023)
1. Metastatic acinar cell carcinoma of the pancreas responding to gemcitabine, 5-fluorouracil and leucovorin therapy: a case report.
Sorscher SM
Eur J Cancer Care (Engl); 2009 May; 18(3):318-9. PubMed ID: 19445023
[TBL] [Abstract][Full Text] [Related]
2. Metastatic Acinar Cell Carcinoma of the Pancreas: A Retrospective Cohort Study on Systemic Chemotherapy and Review of the Literature.
Busch E; Werft W; Bougatf N; Hackert T; Jäger D; Springfeld C; Berger AK
Pancreas; 2021 Mar; 50(3):300-305. PubMed ID: 33835959
[TBL] [Abstract][Full Text] [Related]
3. FOLFOX regimen in pancreatic acinar cell carcinoma: case report and review of the literature.
Simon M; Bioulac-Sage P; Trillaud H; Blanc JF
Acta Oncol; 2012 Mar; 51(3):403-5. PubMed ID: 21961498
[No Abstract] [Full Text] [Related]
4. [A case of pancreatic acinar cell carcinoma with a giant liver metastasis successfully treated with combination of gemcitabine and peroral S-1].
Nishimizu T; Minemura M; Kajiura S; Tokimitsu Y; Itaya Y; Yamawaki H; Kawai K; Tajiri K; Nakayama Y; Hosokawa A; Takahara T; Yasumura S; Shimizu S; Fukuoka J; Ishizawa S; Sawasaki T; Yanagisawa A; Sugiyama T
Gan To Kagaku Ryoho; 2011 Feb; 38(2):309-12. PubMed ID: 21368502
[TBL] [Abstract][Full Text] [Related]
5. Biweekly low-dose sequential gemcitabine, 5-fluorouracil, leucovorin, and cisplatin (GFP): a highly active novel therapy for metastatic adenocarcinoma of the exocrine pancreas.
Araneo M; Bruckner HW; Grossbard ML; Frager D; Homel P; Marino J; DeGregorio P; Mortazabi F; Firoozi K; Jindal K; Kozuch P
Cancer Invest; 2003; 21(4):489-96. PubMed ID: 14533437
[TBL] [Abstract][Full Text] [Related]
6. A case report of a patient with advanced acinar cell carcinoma of the pancreas: long-term survival with regional, systemic and targeted therapy.
Ang C; Herran LA; Lagunes DR; Klimstra DS; Kemeny NE
Tumori; 2013; 99(2):e61-4. PubMed ID: 23748831
[TBL] [Abstract][Full Text] [Related]
7. Irinotecan combined with gemcitabine, 5-fluorouracil, leucovorin, and cisplatin (G-FLIP) is an effective and noncrossresistant treatment for chemotherapy refractory metastatic pancreatic cancer.
Kozuch P; Grossbard ML; Barzdins A; Araneo M; Robin A; Frager D; Homel P; Marino J; DeGregorio P; Bruckner HW
Oncologist; 2001; 6(6):488-95. PubMed ID: 11743211
[TBL] [Abstract][Full Text] [Related]
8. Long-term survival in a patient with acinar cell carcinoma of pancreas. A case report and review of literature.
Antoine M; Khitrik-Palchuk M; Saif MW
JOP; 2007 Nov; 8(6):783-9. PubMed ID: 17993731
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Chemotherapy in Patients with Unresectable or Metastatic Pancreatic Acinar Cell Carcinoma: Potentially Improved Efficacy with Oxaliplatin-Containing Regimen.
Yoo C; Kim BJ; Kim KP; Lee JL; Kim TW; Ryoo BY; Chang HM
Cancer Res Treat; 2017 Jul; 49(3):759-765. PubMed ID: 27857025
[TBL] [Abstract][Full Text] [Related]
10. Gemcitabine/5-flourouracil/leucovorin for the treatment of advanced pancreatic carcinoma.
Malayeri R; Ghassemboland M; Ranjpoor F; Maadi A
Hematol Oncol Stem Cell Ther; 2008; 1(4):221-4. PubMed ID: 20058477
[TBL] [Abstract][Full Text] [Related]
11. Squamous cell carcinoma of the pancreas with cystic degeneration.
Colarian J; Fowler D; Schor J; Poolos S
South Med J; 2000 Aug; 93(8):821-2. PubMed ID: 10963520
[TBL] [Abstract][Full Text] [Related]
12. Nab-paclitaxel plus either gemcitabine or simplified leucovorin and fluorouracil as first-line therapy for metastatic pancreatic adenocarcinoma (AFUGEM GERCOR): a non-comparative, multicentre, open-label, randomised phase 2 trial.
Bachet JB; Hammel P; Desramé J; Meurisse A; Chibaudel B; André T; Debourdeau P; Dauba J; Lecomte T; Seitz JF; Tournigand C; Aparicio T; Meyer VG; Taieb J; Volet J; Monier A; Bonnetain F; Louvet C
Lancet Gastroenterol Hepatol; 2017 May; 2(5):337-346. PubMed ID: 28397697
[TBL] [Abstract][Full Text] [Related]
13. Improvement of Treatment Outcomes for Metastatic Pancreatic Cancer: A Real-world Data Analysis.
Sasaki T; Kanata R; Yamada I; Matsuyama M; Ozaka M; Sasahira N
In Vivo; 2019; 33(1):271-276. PubMed ID: 30587635
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of chemotherapy combined with toripalimab in PD-L1-positive and high tumor mutation burden pancreatic acinar cell carcinoma: case report.
Xu H; Wang X; Zhou S; Hu Q; Cao D
Tumori; 2021 Dec; 107(6):NP24-NP27. PubMed ID: 33345750
[TBL] [Abstract][Full Text] [Related]
15. Triplet combination of gemcitabine, paclitaxel, and carboplatin followed by maintenance 5-fluorouracil and folinic acid in patients with metastatic nasopharyngeal carcinoma.
Leong SS; Wee J; Rajan S; Toh CK; Lim WT; Hee SW; Tay MH; Poon D; Tan EH
Cancer; 2008 Sep; 113(6):1332-7. PubMed ID: 18615622
[TBL] [Abstract][Full Text] [Related]
16. Second-line treatment with oxaliplatin, leucovorin and 5-fluorouracil in gemcitabine-pretreated advanced pancreatic cancer: A phase II study.
Tsavaris N; Kosmas C; Skopelitis H; Gouveris P; Kopterides P; Loukeris D; Sigala F; Zorbala-Sypsa A; Felekouras E; Papalambros E
Invest New Drugs; 2005 Aug; 23(4):369-75. PubMed ID: 16012797
[TBL] [Abstract][Full Text] [Related]
17. Gemcitabine combined with infusional 5-fluorouracil and high-dose leucovorin for the treatment of advanced carcinoma of the pancreas.
Oztop I; Yilmaz U; Yavuzsen T; Yaren A; Tarhan O; Sagol O; Coker A; Alakavuklar M
Chemotherapy; 2004 Jun; 50(3):127-32. PubMed ID: 15282439
[TBL] [Abstract][Full Text] [Related]
18. Pooled efficacy analysis from a phase I-II study of biweekly irinotecan in combination with gemcitabine, 5-fluorouracil, leucovorin and cisplatin in patients with metastatic pancreatic cancer.
Goel A; Grossbard ML; Malamud S; Homel P; Dietrich M; Rodriguez T; Mirzoyev T; Kozuch P
Anticancer Drugs; 2007 Mar; 18(3):263-71. PubMed ID: 17264757
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic acinar cell carcinoma with bilateral ovarian metastases, panniculitis and polyarthritis treated with FOLFIRINOX chemotherapy regimen. A case report and review of the literature.
Callata-Carhuapoma HR; Pato Cour E; Garcia-Paredes B; Fernandez RM; Mendoza Fernandez ML; Fernandez AM; De La Rosa CA; Sotelo Lezama MJ; Cabezas-Camarero S; Sastre Varela J
Pancreatology; 2015; 15(4):440-4. PubMed ID: 25959244
[TBL] [Abstract][Full Text] [Related]
20. Impact on health-related quality of life deterioration-free survival of a first-line therapy combining nab-paclitaxel plus either gemcitabine or simplified leucovorin and fluorouracil for patients with metastatic pancreatic cancer: Results of the randomized phase II AFUGEM GERCOR clinical trial.
Charton E; Bachet JB; Hammel P; Desramé J; Chibaudel B; Cohen R; Debourdeau P; Dauba J; Lecomte T; Seitz JF; Tournigand C; Aparicio T; Guerin-Meyer V; Taieb J; Volet J; Louvet C; Anota A; Bonnetain F
Cancer Med; 2019 Sep; 8(11):5079-5088. PubMed ID: 31314957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
